Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Cash from Financing Activities (2023 - 2025)

Guardian Pharmacy Services' Cash from Financing Activities history spans 3 years, with the latest figure at -$758000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 98.43% year-over-year to -$758000.0; the TTM value through Dec 2025 reached -$7.1 million, up 70.1%, while the annual FY2025 figure was -$7.1 million, 70.1% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$758000.0 at Guardian Pharmacy Services, up from -$1.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $44.9 million in Q3 2024 and bottomed at -$48.3 million in Q4 2024.
  • The 3-year median for Cash from Financing Activities is -$2.7 million (2025), against an average of -$4.9 million.
  • The largest annual shift saw Cash from Financing Activities tumbled 263.62% in 2024 before it surged 98.43% in 2025.
  • A 3-year view of Cash from Financing Activities shows it stood at -$13.3 million in 2023, then crashed by 263.62% to -$48.3 million in 2024, then soared by 98.43% to -$758000.0 in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Cash from Financing Activities are -$758000.0 (Q4 2025), -$1.5 million (Q3 2025), and -$2.1 million (Q2 2025).